Oldest pages

Showing below up to 50 results in range #101 to #150.

101. Saliva: An Overlooked yet Critical Diagnostic Tool in Detection of Nipah Virus (01:59, 7 February 2026)
102. Knowledge, Attitudes, Risk Perception, Preparedness and Vaccine Intent of Health Care Providers towards the Nipah Virus in South India (01:59, 7 February 2026)
103. Nipah Virus: An Overview of the Current Status of Diagnostics and Their Role in Preparedness in Endemic Countries (01:59, 7 February 2026)
104. Nipah Virus: A Multidimensional Update (01:59, 7 February 2026)
105. Zoonotic Paramyxoviruses: Evolution, Ecology, and Public Health Strategies in a Changing World (01:59, 7 February 2026)
106. Risk of Nipah Virus Seroprevalence in Healthcare Workers: A Systematic Review with Meta-Analysis (01:59, 7 February 2026)
107. Zika, Nipah and Kala-azar: Emerging lethal infectious diseases amid COVID-19 as an escalating public health threat in South India (01:59, 7 February 2026)
108. Prophylactic protection from lethal henipavirus disease mediated by Nipah-derived defective interfering particles is influenced by challenge virus strain and viral species (02:00, 7 February 2026)
109. Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition (02:00, 7 February 2026)
110. Public Health Policy and Outbreak Response (02:01, 7 February 2026)
111. 1-s2.0-S0042682207007593-main (02:14, 7 February 2026)
112. Designing potential siRNA molecules for silencing the gene of the nucleocapsid protein of Nipah virus: A computational investigation (02:15, 7 February 2026)
113. In silico prediction of interaction between Nipah virus attachment glycoprotein and host cell receptors Ephrin-B2 and Ephrin-B3 in domestic and peridomestic mammals (02:15, 7 February 2026)
114. Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance (02:15, 7 February 2026)
115. Full genome sequence of Nipah virus from an outbreak in India (02:15, 7 February 2026)
116. An Immunoinformatics Prediction of Novel Multi-Epitope Vaccines Candidate Against Surface Antigens of Nipah Virus (02:15, 7 February 2026)
117. Characterization of Nipah Virus from Outbreaks in Bangladesh, 2008–2010 (02:15, 7 February 2026)
118. A Novel Model of Lethal Hendra Virus Infection in African Green Monkeys and the Effectiveness of Ribavirin Treatment (02:15, 7 February 2026)
119. Molecular Pathogenesis of Nipah Virus (02:15, 7 February 2026)
120. Glycoprotein attachment with host cell surface receptor ephrin B2 and B3 in mediating entry of nipah and hendra virus: a computational investigation (02:15, 7 February 2026)
121. Reproducible generation of Nipah virus pseudovirions with uniform incorporation of F and G surface glycoproteins for high-throughput neutralization assays (02:15, 7 February 2026)
122. Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature (02:15, 7 February 2026)
123. Molecular characterization of Nipah virus from Pteropus hypomelanus in Southern Thailand (02:16, 7 February 2026)
124. Nipah Virus Sequences from Humans and Bats during Nipah Outbreak, Kerala, India, 2018 (02:16, 7 February 2026)
125. High Pathogenicity of Nipah Virus from Pteropus lylei Fruit Bats, Cambodia (02:16, 7 February 2026)
126. Genetic Diversity and Geographic Spread of Henipaviruses (02:16, 7 February 2026)
127. Nipah virus: pathogenesis, genome, diagnosis, and treatment (02:16, 7 February 2026)
128. Revolutionizing Nipah virus vaccinology: insights into subunit vaccine development strategies and immunological advances (02:16, 7 February 2026)
129. An Immunoinformatic-Based In Silico Identification on the Creation of a Multiepitope-Based Vaccination Against the Nipah Virus (02:16, 7 February 2026)
130. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis (02:16, 7 February 2026)
131. A comparative genomic approach to decipher the mutations associated with Nipah viral human isolates from southeast Asia (02:16, 7 February 2026)
132. Development of Nipah virus-specific IgM & IgG ELISA for screening human serum samples (02:16, 7 February 2026)
133. Genomic characterization, transcriptome analysis, and pathogenicity of the Nipah virus (Indian isolate) (02:16, 7 February 2026)
134. Functional and antigenic landscape of the Nipah virus receptor-binding protein (02:16, 7 February 2026)
135. Genetic diversity of Nipah virus in Bangladesh (02:16, 7 February 2026)
136. Paramyxoviruses in rodents: A review (02:16, 7 February 2026)
137. Pathogenicity and virulence of henipaviruses (02:16, 7 February 2026)
138. Streamlined detection of Nipah virus antibodies using a split NanoLuc biosensor (02:16, 7 February 2026)
139. A Novel DNAzyme-Based Fluorescent Biosensor for Detection of RNA-Containing Nipah Henipavirus (02:16, 7 February 2026)
140. Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents (02:16, 7 February 2026)
141. Antivirotics based on defective interfering particles: emerging concepts and challenges (02:16, 7 February 2026)
142. Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection (02:16, 7 February 2026)
143. Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease (02:16, 7 February 2026)
144. The latest advancements in Sosuga virus (SOSV) research (02:16, 7 February 2026)
145. Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease (02:16, 7 February 2026)
146. Nipah Virus Bangladesh Infection Elicits Organ-Specific Innate and Inflammatory Responses in the Marmoset Model (02:16, 7 February 2026)
147. The Genetic Diversity of Nipah Virus Across Spatial Scales (02:16, 7 February 2026)
148. Experimental Infection of Syrian Hamsters With Aerosolized Nipah Virus (02:16, 7 February 2026)
149. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters (02:16, 7 February 2026)
150. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge (02:17, 7 February 2026)